CNCR stock icon

ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR

$14.18
1.98%

Market Cap: $16.7M

0
Funds holding %
of 6,686 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

3.02% less ownership

Funds ownership: 11.81% [Q1] → 8.79% (-3.02%) [Q2]

25% less funds holding

Funds holding: 16 [Q1] → 12 (-4) [Q2]

46% less capital invested

Capital invested by funds: $2.61M [Q1] → $1.4M (-$1.21M) [Q2]

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Research analyst outlook

We haven’t received any recent analyst ratings for CNCR.

Financial journalist opinion